This website uses cookies to enhance the user experience.
||
B

BAYER NORWAY AS998 720 516

Purchase and sale
Limited company
Drammensveien 288 0283 OSLO, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

BAYER NORWAY AS

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
CT

Christiane Temminghoff1977

Chairman of the board
EH

Erik Helstad1967

Years since formation
13 years
since Aug 16, 2012
Type
Limited company
VAT registered
Yes
Number of employees
9

Ownership

Number of shares and share classes
30,300
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Total operating income 2024
1,763,000
NOK
Annual total result 2024
33,521,000
NOK
Total equity 2024
654,254,000
NOK
Last update: Aug 12, 2025

Management

Management / administration

NameRoleShares
CT

Christiane Temminghoff

1977

Managing Director/CEO-

Board

NameRoleShares
AS

Ann-Christin Siltvedt

1970

Board Member-
EH

Erik Helstad

1967

Chairman-

Others

NameRoleShares
D
DELOITTE AS
Auditor-
A
AZETS INSIGHT AS
Accountant-
Last update: Jun 13, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
NS

Nordic Se Bayer

Ordinary shares
30,300
100 %

Shares owned by the BAYER NORWAY AS

NameShare classTotal number of sharesShare
B
BAYER AS
Ordinary shares
800
100 %
Last update: Jun 2, 2025

Group structure

  • BAYER NORWAY AS
    Total operating income 2024: NOK 1,763,000
    Operating profit 2024: NOK -285,000
    Employees: 9

Financials

in NOK

Summary

Year2024202320222021
Total operating income
1,763,000
1,853,038
1,941,680
1,667,357
Annual Total Result
33,521,000
32,662,779
-1,034,652,305
-20,820,857
Total assets
1,068,043,000
1,071,066,153
1,073,108,834
2,050,736,193
Total liabilities
413,789,000
592,333,507
1,012,038,967
1,005,006,521
Total equity
654,254,000
478,732,646
61,069,867
1,045,729,672

P&L

Year2024202320222021
Total operating income
1,763,000
1,853,038
1,941,680
1,667,357
Total operating costs
2,048,000
1,953,465
2,313,101
2,321,461
Operating result
-285,000
-100,427
-371,421
-654,104
Financial income/costs
11,576,000
39,809,491
-1,041,051,161
-11,194,700
Profit before tax
11,291,000
39,709,064
-1,041,422,582
-11,848,804
Total tax & extraordinary income/cost
-22,230,000
7,046,285
-6,770,277
8,972,053
Annual Total Result
33,521,000
32,662,779
-1,034,652,305
-20,820,857

Balance overview

Year2024202320222021
Total fixed assets
1,037,039,000
1,014,809,697
1,021,855,982
2,041,027,041
Total current assets
31,004,000
56,256,456
51,252,852
9,709,152
Total assets
1,068,043,000
1,071,066,153
1,073,108,834
2,050,736,193
Short term debt
7,789,000
7,333,507
14,538,967
10,006,521
Long term debt
406,000,000
585,000,000
997,500,000
995,000,000
Total liabilities
413,789,000
592,333,507
1,012,038,967
1,005,006,521
Contributed capital
1,694,031,000
1,552,030,710
1,167,030,711
1,117,038,211
Retained earnings
-1,039,777,000
-1,073,298,064
-1,105,960,844
-71,308,539
Total equity
654,254,000
478,732,646
61,069,867
1,045,729,672
Total equity and liabilities
1,068,043,000
1,071,066,153
1,073,108,834
2,050,736,193

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods